|
Alector Inc (NASDAQ: ALEC) |
|
Alector Inc
ALEC's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Alector Inc growth rates, revenue grew
by 68.43 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 1960
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 13.31 %
Alector Inc net loss decreased from $-44 millions, to $-42 millions in III. Quarter 2024,
• More on ALEC's Growth
|
|
Alector Inc realized a net loss in trailing twelve months.
Alector Inc realized cash reduction of $ -0.66 per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 2.71.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.63.
• More on ALEC's Valuation
|
|
|
|
|
Alector Inc realized net loss in trailing twelve months.
Alector Inc realized cash outflow of $ -0.66per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 2.71.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.63.
Alector Inc Price to Book Ratio is at 1.4 lower than Industry Avg. of 412.31. and higher than S&P 500 Avg. of 0.01
• More on ALEC's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com